Eam Investors, LLC Alpine Immune Sciences, Inc. Transaction History

Eam Investors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$17.75 - $41.6 $1.56 Million - $3.65 Million	-87,786 Reduced 53.96%	74,899 $2.97 Million
Q4 2023 Feb 13, 2024	BUY	$8.54 - $20.22 $1.39 Million - $3.29 Million	162,685 New	162,685 $3.1 Million
Q1 2021 May 11, 2021	SELL	$10.02 - $13.92 $633,875 - $880,593	-63,261 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$7.42 - $15.96 $469,396 - $1.01 Million	63,261 New	63,261 $797,000

56.2K

Ticker ALPN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 44,006,700
Description
Alpine Immune Sciences, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of protein-based immunotherapies for the treatment of cancer, autoimmune/inflammatory disorders, and other diseases. Its product pipeline includes ALPN-101, an inducible T cell costimulator (ICOS)/cluster of differentiation 28 (CD28...

Get notified when there are updates to the investment portfolio of Eam Investors, LLC, based on Form 13F filings with the SEC.

Stay updated on Eam Investors, LLC with notifications on news.